Hussein N Rubaiy

7PUBLICATIONS
74CO-AUTHORS
PharmacogenomicsClinical pharmacology and therapeuticsMolecular targetsBiomolecular modelling and designComputer vision
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2026
Attitudes of Swedish primary care physicians toward GLP-1 receptor agonists for overweight and obesity: a cross-sectional survey.

|Dec 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.

Stephen P H Alexander, Jörg Striessnig, Alasdair J Gibb

|Oct 15, 2024
Transient Receptor Potential Canonical Channels in Cardiovascular Pathology and Their Modulators.

Hussein N Rubaiy

|Jul 05, 2019
Mibefradil, a T-type Ca2+ channel blocker also blocks Orai channels by action at the extracellular surface.

Pengyun Li, Hussein N Rubaiy, Gui-Lan Chen

|Jan 19, 2019
Treasure troves of pharmacological tools to study transient receptor potential canonical 1/4/5 channels.

Hussein N Rubaiy

|Jun 03, 2018
Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels.

Hussein N Rubaiy, Melanie J Ludlow, Karsten Siems

Pageof 2

Frequent Collaborators

1 joint publications

Shang-Zhong Xu

1 joint publications

Stephen P H Alexander

1 joint publications

Jörg Striessnig

1 joint publications

Alasdair J Gibb